✦ LIBER ✦

Cholinesterase inhibitor use is associated with increased plasma levels of anti-Abeta 1–42 antibodies in Alzheimer's disease patients

✍ Scribed by Elisa Conti; Gloria Galimberti; Lucio Tremolizzo; Alessandro Masetto; Diletta Cereda; Clara Zanchi; Fabrizio Piazza; Marco Casati; Valeria Isella; Ildebrando Appollonio; Carlo Ferrarese

Book ID: 116772660
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 174 KB
Volume: 486
Category: Article
ISSN: 0304-3940
DOI: 10.1016/j.neulet.2010.09.050

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P3-002 Plasma levels of Abeta1–40 and Ab

P3-002 Plasma levels of Abeta1–40 and Abeta1–42 in Alzheimer's disease during treatment with the dual cholinesterase inhibitor rivastigmine

✍ Sobow, Tomasz; Kloszewska, Iwona 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Infusion of Intravenous Immunoglobulin (

Infusion of Intravenous Immunoglobulin (IVIg) Containing anti-Abeta Antibodies is Associated with a Decrease of Abeta in Cerebrospinal Fluid (CSF) and Increase of Abeta in Blood from 8 Patients with Mild Alzheimer's Disease (AD)

✍ WEKSLER, M; SZABO, P; ADAMIAK, B; BURGUT, T; MONTHE, C; YOUNKIN, S; YOUNKIN, L; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 48 KB